Literature DB >> 16249279

Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.

Frank González1, Neal S Rote, Judi Minium, John P Kirwan.   

Abstract

CONTEXT: Insulin resistance and chronic low level inflammation are often present in women with polycystic ovary syndrome (PCOS).
OBJECTIVE: The purpose of this study was to determine the effects of hyperglycemia on reactive oxygen species (ROS) generation from mononuclear cells (MNCs) in PCOS.
DESIGN: This was a prospective controlled study.
SETTING: The study was conducted at an academic medical center. PATIENTS: The study population consisted of 16 women with PCOS (eight lean, eight obese) and 15 age- and body composition-matched controls (eight lean, seven obese). MAIN OUTCOME MEASURES: Insulin sensitivity was derived from a 2-h, 75-g oral glucose tolerance test (IS(OGTT)). ROS generation and p47(phox) protein expression were quantitated from MNCs obtained from blood drawn fasting and 2 h after glucose ingestion.
RESULTS: IS(OGTT) was lower in PCOS, compared with controls (3.1 +/- 0.3 vs. 6.3 +/- 0.9, P < 0.003). The percent change in ROS generation from MNCs was higher in lean and obese PCOS, compared with lean controls (138.8 +/- 21.3 and 154.2 +/- 49.1 vs. 0.6 +/- 12.7, P < 0.003). The percent change in ROS generation from MNCs correlated positively with glucose area under the curve (r = 0.38, P < 0.05), and plasma levels of testosterone (r = 0.59, P < 0.002) and androstenedione (r = 0.50, P < 0.009). The percent change in p47(phox) from MNCs was also higher in lean and obese PCOS, compared with lean controls (36.2 +/- 18.2 and 39.1 +/- 8.0 vs. -13.7 +/- 8.7, P < 0.02), and correlated negatively with IS(OGTT) (r = -0.39, P < 0.05).
CONCLUSION: ROS generation from MNCs in response to hyperglycemia is increased in PCOS independent of obesity. The resultant oxidative stress may contribute to a proinflammatory state that induces insulin resistance and hyperandrogenism in women with this disorder.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16249279     DOI: 10.1210/jc.2005-1696

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  111 in total

Review 1.  Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions.

Authors:  Kristen Farrell; Michael H Antoni
Journal:  Fertil Steril       Date:  2010-05-14       Impact factor: 7.329

2.  Lipid-induced mononuclear cell cytokine secretion in the development of metabolic aberration and androgen excess in polycystic ovary syndrome.

Authors:  F González; R V Considine; O A Abdelhadi; A J Acton
Journal:  Hum Reprod       Date:  2020-05-01       Impact factor: 6.918

Review 3.  Could oxidative stress influence the in-vitro maturation of oocytes?

Authors:  Catherine M H Combelles; Sajal Gupta; Ashok Agarwal
Journal:  Reprod Biomed Online       Date:  2009-06       Impact factor: 3.828

4.  Evidence of proatherogenic inflammation in polycystic ovary syndrome.

Authors:  Frank González; Neal S Rote; Judi Minium; John P Kirwan
Journal:  Metabolism       Date:  2009-07       Impact factor: 8.694

Review 5.  Oxidative stress and antioxidants: exposure and impact on female fertility.

Authors:  Elizabeth H Ruder; Terryl J Hartman; Jeffrey Blumberg; Marlene B Goldman
Journal:  Hum Reprod Update       Date:  2008-06-04       Impact factor: 15.610

6.  Glucose-stimulated oxidative stress in mononuclear cells is related to pancreatic β-cell dysfunction in polycystic ovary syndrome.

Authors:  Steven K Malin; John P Kirwan; Chang Ling Sia; Frank González
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

7.  Pre-diagnostic urinary 15-F2t -isoprostane level and liver cancer risk: Results from the Shanghai Women's and Men's Health Studies.

Authors:  Xiao Ma; Yu-Ting Tan; Yang Yang; Jing Gao; Hong-Lan Li; Wei Zheng; Qing Lan; Nathaniel Rothman; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  Int J Cancer       Date:  2018-08-10       Impact factor: 7.396

8.  Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection.

Authors:  Amal K Seleem; Abdel Aziz El Refaeey; Dalia Shaalan; Yasser Sherbiny; Ahmed Badawy
Journal:  J Assist Reprod Genet       Date:  2014-02-14       Impact factor: 3.412

9.  Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome.

Authors:  Frank González; John P Kirwan; Neal S Rote; Judi Minium
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-18       Impact factor: 4.310

10.  Inflammation in response to glucose ingestion is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome.

Authors:  Frank González; Chang Ling Sia; Marguerite K Shepard; Neal S Rote; Judi Minium
Journal:  J Clin Endocrinol Metab       Date:  2012-08-17       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.